Module 8: Non-infectious Disease and Disorders
9 dot points across 4 inquiry questions, in syllabus order. Each dot point has a focused answer, with exam-style questions and worked answers where available.
Inquiry Question 1: How is an organism's internal environment maintained in response to a changing external environment?
Inquiry Question 2: Do non-infectious diseases cause more deaths than infectious diseases?
Causes of non-infectious disease. Covers genetic, environmental, nutritional, lifestyle and age-related categories with named examples, distinguishing causal mechanisms and risk factors.
HSC Biology Module 8 answer on named genetic disorders - cystic fibrosis (autosomal recessive, CFTR), sickle cell anaemia (autosomal recessive, HBB) and Huntington's disease (autosomal dominant, HTT) - with their molecular causes, effects, and pedigree and Punnett-square analysis.
Nutritional and environmental disease. Covers type 2 diabetes, cardiovascular disease (atherosclerosis) and mesothelioma, with mechanisms, risk factors and burden of disease in Australia.
Epidemiology. Defines incidence, prevalence and mortality, compares cohort, case-control and cross-sectional study designs, and applies them to the Doll and Hill lung cancer studies.
Inquiry Question 3: Why are epidemiological studies used?
Inquiry Question 4: How can technologies be used to assist people who experience disorders?
Loss of kidney function and the technologies that assist it. Covers kidney and nephron structure and function (filtration, reabsorption, secretion, homeostasis), causes of kidney failure, and an evaluation of haemodialysis, peritoneal dialysis and transplant.
Technologies that assist sense-organ disorders: how the ear transduces sound (conductive vs sensorineural hearing loss; hearing aids, BAHA, cochlear implants) and how the lens focuses light (myopia, hyperopia, presbyopia, cataract; lenses, LASIK, IOLs), each linked to the structure it fixes.
Disease treatment. Covers pharmaceutical intervention (insulin, statins, CFTR modulators), gene therapy (Casgevy for sickle cell, Luxturna for vision), and lifestyle change as both prevention and treatment.
